Jamie L. Reynoso - Jan 1, 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO, Medicare Advantage
Signature
/s /Scott Leffler as attorney-in-fact for Jamie L. Reynoso
Stock symbol
CLOV
Transactions as of
Jan 1, 2024
Transactions value $
-$1,481
Form type
4
Date filed
1/3/2024, 04:33 PM
Previous filing
Dec 19, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability -$1.48K -1.56K -0.06% $0.95 2.53M Jan 1, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 1, 2024, of the last third of the number of restricted stock units (RSUs) granted to the Reporting Person on January 31, 2022, upon the achievement of certain performance criteria underlying a performance-based RSU award that was granted on July 16, 2021.
F2 Amount of securities beneficially owned reflects the amount in the Form 4/A filed on January 3, 2024.

Remarks:

EX-24 Power of Attorney